SoniVie publicizes developments in its renal denervation program: REDUCED-1 pilot research outcomes, radial entry First-In-Human outcomes, and FDA pivotal IDE approval of The THRIVE world research – PR Newswire APAC – PR Newswire Asia

SoniVie publicizes developments in its renal denervation program: REDUCED-1 pilot research outcomes, radial entry First-In-Human outcomes, and FDA pivotal IDE approval of The THRIVE world research – PR Newswire APAC  PR Newswire Asia

[ad_2]